Company attributes
Industry
B2X
CEO
Number of Employees (Ranges)
51 – 200
Full Address
30 Avenue Gustave Eiffel, Bat A, Pessac, Nouvelle-Aquitaine 33600, FR
Founded Date
2018
Total Funding Amount (USD)
157,300,000
Latest Funding Round Date
September 13, 2021
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
75,000,000
Public/Private
Private
THE VISION
TreeFrog Therapeutics was created to provide access to safe, efficient and affordable cell therapies for millions of patients.
TreeFrog Therapeutics is advancing a pipeline of cell therapies with the aim of a first-in-human trial in 2024.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
